Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6533
+0.0221 (3.50%)
May 13, 2025, 4:00 PM - Market closed

MTNB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-24.25-22.94-21-23.28-22.45
Upgrade
Depreciation & Amortization
0.970.940.90.780.77
Upgrade
Other Amortization
--0.210.250.24
Upgrade
Loss (Gain) From Sale of Assets
-000-
Upgrade
Asset Writedown & Restructuring Costs
4.43----
Upgrade
Loss (Gain) From Sale of Investments
----0.01
Upgrade
Stock-Based Compensation
3.24.955.234.294.56
Upgrade
Other Operating Activities
-0.10.110.291.2-
Upgrade
Change in Accounts Payable
-0.42-0.1-0.320.59-0.33
Upgrade
Change in Other Net Operating Assets
0.291.77-4.470.95-0.18
Upgrade
Operating Cash Flow
-15.89-15.28-19.16-15.22-17.37
Upgrade
Capital Expenditures
--0.22-0.89-0.26-0.01
Upgrade
Investment in Securities
9.2113.465.7717.03-40.66
Upgrade
Investing Cash Flow
9.2113.244.8816.77-40.67
Upgrade
Long-Term Debt Repaid
-0.01-0.01-0.02-0.03-0.05
Upgrade
Total Debt Repaid
-0.01-0.01-0.02-0.03-0.05
Upgrade
Net Debt Issued (Repaid)
-0.01-0.01-0.02-0.03-0.05
Upgrade
Issuance of Common Stock
9.18-0.1748.1
Upgrade
Financing Cash Flow
9.17-0.010.086.9748.05
Upgrade
Net Cash Flow
2.5-2.04-14.28.51-9.99
Upgrade
Free Cash Flow
-15.89-15.5-20.05-15.48-17.37
Upgrade
Free Cash Flow Margin
--1413.87%-628.86%-46918.18%-10972.81%
Upgrade
Free Cash Flow Per Share
-3.27-3.57-4.62-3.68-4.41
Upgrade
Levered Free Cash Flow
-7.45-6.96-14.39-8.25-9.76
Upgrade
Unlevered Free Cash Flow
-7.45-6.96-14.6-8.5-10
Upgrade
Change in Net Working Capital
-0.99-2.234.47-2.150.2
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q